Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetes

Fig. 3

Receiver operating characteristic curves of risk models of established risk factors with or without levels of PCSK9 for predicting major adverse cardiovascular events in the whole cohort (a), DM patients (b) and non-DM patients (c). PCSK9 proprotein convertase subtilisin/kexin type 9, DM diabetes mellitus, Non-DM non-diabetes mellitus, AUC area under the curve

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840